MIP PHARMA
The MiP Group is an internationally positioned manufacturer and distributor of generic pharmaceuticals, with a primary focus on anti-infectives.
In addition to its core portfolio, the company offers over-the-counter (OTC) medications and medical devices. MiP serves a diverse customer base, including hospitals, pharmacies, and medical specialists, across 23 countries throughout Germany and Eastern Europe.
In partnership with the management team and seasoned industry experts, capiton's investment strategy focuses on leveraging MiP's extensive local production capacities and international footprint. The goal is to further solidify its market leadership and drive continued growth across its target markets.


SHAREHOLDER
Capiton
FINANCING
Acquisition Financing
INDUSTRY
Pharmaceuticals
WEBSITE
